References
- Vilhardt H. Basic pharmacology of desmopressin: a review. Drug Invest 1990; 2(suppl. 5)2–8
- Law SL, Huang KJ, Chou HY. Preparation of desmopressin-containing liposomes for intranasal delivery. J Con Rel 2001; 70: 375–382
- Kahns AH, Buur A, Bundgaard H. Prodrugs of peptides. 18. Synthesis and evaluation of various esters of desmopressin (dDAVP). Pharm Res 1993; 10: 68–74
- Sedlak D, Szymkowiak J, Saar A, Owen A. Stability of desmopressin in microemulsion formulations with soft gelatin capsules. Proc Con Rel Soc 1999; 26: 911–912
- Rinderknecht H, Fleming RM. A new, highly sensitive and specific assay for chymotrypsin. Clin Chim Acta 1980; 59: 139–146
- Lundin S, Bengtsson HI, Folkesson HG, Westrom BR. Degradation of [mercapopropionic acid 1, d-arginine 8]-vasopressin (dDAVP) in pancreatic juice and intestinal mucosa homogenate. Pharmacol Toxicol 1989; 65: 92–95
- Lang JK. Quantitative determination of cholesterol in liposome drug products and raw materials by high-performance liquid chromatograpy. J Chrom 1990; 507: 157–163
- Grit M, Crommelin DJA, Lang J. Determination of phosphatidylcholine, phosphatidylglycerol, and their lyso forms from liposome dispersions by high-performance liquid chromatography using high-sensitivity refractive index detection. J Chrom 1991; 585: 239–246
- Zhou XH, Li Wan Po A. Peptide and protein drugs: I. Therapeutic applications, absorption, and parenteral administration. Int J Pharm 1991; 75: 97–115
- Law SL, Shih CL. Characterization of calcitonin-containing liposome formulations for intranasal delivery. J Microencap 2001; 18: 211–221
- Lee KC, Lee YJ, Song HM, Chun CJ, DeLuca PP. Degradation of synthetic salmon calcitonin in aqueous solution. Pharm Res 1992; 9: 1521–1523
- Patel K, Borchardt RT. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharm Res 1990; 7: 703–711
- Helm VJ, Muller BW. Stability of gonadorelin and triptorelin in aqueous solution. Pharm Res 1990; 7: 1253–1256
- Powell MF, Sanders LM, Rogerson A, Si V. Parenteral peptide formulations: chemical and physical properties of native luteinizing hormone-releasing hormone (LHRH) and hydrophobic analogues in aqueous solution. Pharm Res 1991; 8: 1258–1263
- Fredholt K, Ostergaard J, Savolainen J, Friis GJ. α-Chymotrypsin-catalyzed degradation of desmopressin (dDAVP): influence of pH, concentration, and various cyclodextrins. Int J Pharm 1999; 178: 223–229
- Weingaarten C, Moufti A, Delattre J, Puisieux F, Couvreur P. Protection of insulin from enzymatic degradation by its association to liposomes. Int J Pharm 1985; 26: 251–257
- Kato Y, Hosokawa T, Hayakawa E, Ito K. Influence of liposomes on tryptic digestion of insulin. Biol Pharm Bull 1993; 16: 457–461